Search

everythinglearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Topical tofacitinib is effective and safe for treating alopecia areata.

Dutasteride reduces DHT more effectively than finasteride.

Baricitinib can cause excessive hair growth.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Dutasteride may help prevent prostate cancer, but more research is needed.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Many patients on new leukemia drugs had mild to moderate skin reactions.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tofacitinib helped a woman with total-body hair loss grow her hair back.